The Neuro Experience

Longevity Surgeon: The Biomarkers That Predict If You'll Get Cancer or Alzheimer's

55 snips
Mar 4, 2026
Dr. Darshan Shah, a board-certified surgeon turned longevity physician and founder of Next Health, shares his switch from operating rooms to root-cause care. He discusses why routine labs miss early disease, which biomarkers flag cancer and Alzheimer risk, liquid biopsy and full-body MRI screening, AI-driven dashboards for personalized prevention, and promising regenerative approaches like Yamanaka-factor research.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Blood Tests Now Mirror Brain PET Changes

  • Blood biomarkers P‑tau217/181 and amyloid ratios now correlate with PET findings and can detect Alzheimer’s pathology years before symptoms.
  • Darshan highlights these markers let clinicians track response to lifestyle interventions over time.
ADVICE

Combine APOE Testing With Blood Flow And Metabolic Interventions

  • If brain biomarkers are abnormal, get APOE genotyping and intensify preventive measures proportionally to genetic risk.
  • Treat blood flow, control hypertension, improve nitric oxide and exercise (especially HIIT) to lower Alzheimer's risk.
ADVICE

Track Blood Pressure At Home And Consider Continuous Monitoring

  • Buy an automatic home blood pressure monitor and track readings correctly (morning seated arm, multiple readings) to catch hidden hypertension.
  • Consider continuous BP monitors (Helo) to find daytime spikes and adjust lifestyle or meds accordingly.
Get the Snipd Podcast app to discover more snips from this episode
Get the app